HIGHLIGHTS
- who: Contraception (EC and colleagues from the India Institute of Medical Sciences, Delhi, IND have published the research work: Review began 11/15/2022 Review ended 11/22/2022 Published 11/28/2022 u00a9 Copyright, in the Journal: (JOURNAL) of November/28,/2022
- what: Throughout the history of medicine, levonorgestrel intrauterine system (LNG-IUS) or Mirena 52 mg has not been in the recommendation as a method of EC, the primary reason being the nonavailability of data to support its role in the above-mentioned field of contraception. The aim of this review was to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.